Company Filing History:
Years Active: 2021
Title: Jorge Sepulveda: Innovator in Immunogenic Compositions
Introduction
Jorge Sepulveda is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of immunology, particularly in the development of innovative compositions for treating Her2/neu positive tumor diseases. With a total of 2 patents, his work is paving the way for advancements in medical treatments.
Latest Patents
One of Jorge's latest patents is an immunogenic composition that includes a directed adjuvant and an immunogen linked to specific peptidic alpha-helices. This invention aims to enhance the immune response against Her2/neu positive tumors. Another significant patent is the coiled-coil connector, which connects two molecules through a helical coiled coil-type structure. This connector is designed to facilitate the interaction between polypeptide chains in multimeric proteins.
Career Highlights
Jorge Sepulveda is currently associated with Oncoqr Ml GmbH, where he continues to innovate in the field of immunology. His work focuses on developing solutions that can improve patient outcomes in cancer treatment. His expertise and dedication to research have established him as a key figure in his field.
Collaborations
Jorge collaborates with esteemed colleagues such as Geert Mudde and Christopher Taus. Their combined efforts contribute to the advancement of research and development in immunogenic therapies.
Conclusion
Jorge Sepulveda's contributions to immunology through his patents and collaborations highlight his commitment to improving cancer treatment. His innovative approaches are essential in the ongoing fight against tumor diseases.